Nymox: quarterly net loss increases, product sales up slightly

By Lisa Kerner

Charlotte, N.C., Aug. 11 - Nymox Pharmaceutical Corp. reported a second-quarter 2006 net loss of $1.4 million, or $0.05 per share, up from a net loss of $847,299, or $0.03 per share, for same period in 2005.

The company attributed the increase to stock-based compensation costs as well as an increase in research and development expenditures of $132,803.

Product sales for the quarter were up slightly at $117,690 from $116,820 for the prior-year period.

Nymox is a pharmaceutical company based in Hasbrouck Heights, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.